Search
Immunovant Inc
IMVTAdd to Watchlist
38.620USD
-0.860-2.18%
Close 07-31 16:00（ET）Quotes delayed by 15 min
7.88BMarket Cap
LossP/E TTM
IMVT Financials
See Immunovant Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Immunovant Inc Earnings Date
Latest Release
Aug 6, 2026
EPS / Forecast
--/-0.62
Revenue / Forecast
--/0.00
Period
FY2026 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-2.77
-1.51%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of Immunovant Inc?
According to Immunovant Inc's FY2026 earnings report, its current assets were 948.82M, with a year-on-year change of 23.60.
What are the total assets of Immunovant Inc?
According to Immunovant Inc's FY2026 earnings report, its total assets of Immunovant Inc were 957.01M, with a year-on-year change of 23.29.
What are the total liabilities of Immunovant Inc?
According to Immunovant Inc's FY2026 earnings report, its total liabilities of Immunovant Inc were 104.42M, with a year-on-year change of 51.83.
What is the total equity of Immunovant Inc?
According to Immunovant Inc's FY2026 earnings report, its total equity of Immunovant Inc was 852.59M, with a year-on-year change of 20.52.
What is the net operating income of Immunovant Inc?
According to Immunovant Inc's FY2026 earnings report, its net operating income of Immunovant Inc was -493.95M, with a year-on-year change of -12.73.
What is the net investment of Immunovant Inc?
According to Immunovant Inc's FY2026 earnings report, its net investment of Immunovant Inc was -8.00K, with a year-on-year change of 98.95.
What is the net financing of Immunovant Inc?
According to Immunovant Inc's FY2026 earnings report, its net financing of Immunovant Inc was 595.76M, with a year-on-year change of 31.08.
What is the Earnings Per Share (EPS) of Immunovant Inc?
According to Immunovant Inc's FY2026 earnings report, its Earnings Per Share (EPS) was -2.77, with a year-on-year change of -1.51.
What is the net income of Immunovant Inc?
According to Immunovant Inc's FY2026 earnings report, its net income was -505.61M, with a year-on-year change of -22.17.
What is the Return on Equity (ROE) of Immunovant Inc?
According to Immunovant Inc's FY2026 earnings report, its Return on Equity (ROE) was -64.82, with a year-on-year change of -3.78.
What is the Return on Assets (ROA) of Immunovant Inc?
According to Immunovant Inc's FY2026 earnings report, its Return on Assets (ROA) was -58.34, with a year-on-year change of -1.69.
What is the operating profit of Immunovant Inc?
According to Immunovant Inc's FY2026 earnings report, its operating profit was -493.95M, with a year-on-year change of -12.73.